Mayasari Lim, PhD

Technology evangelist for #celltherapy #regenmed #bioprinting. Start each day with #compassion. Employed by FUJIFILM Irvine Scientific but tweets are my own.

[Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 @BLLPHD]

Exemplary, clear, concise review: CAR T cell combination therapies to treat #cancer w/ the most efficient figure ever! 😉 & table of clinical trials testing different agents to enhance #CARTCell efficacy. #immunotherapy @ca@carlhjune @UgiUslu @Cancer_Cell @msofiacastelli https://t.co/bfFISSizCi

[Mayasari Lim, PhD @MayasariL]

Candid and open conversation on #bioprinting great listen!
3DPOD Episode 196: Bioprinting and Biofabrication with Dietmar Hutmacher, Queensland University of Technology https://t.co/k2CtaQxBi3

[Peter Zandstra @PZandstra]

Wonderful opportunity for a great position in our growing School of BME. #biomaterials #3dprinting #tissue_engineering See details below 👇 and please repost.

[Khoon Lim @Khoonono]

Have a look at this new global health foresight report on 3D bioprinting from @WHO -> https://t.co/paG6KRmz8n. Thanks for having me as a core expert on this project to discuss the future and potential of bioprinting. @CPC_usyd @ASBTE1 @ISBioFab @syd_health

[Mayasari Lim, PhD @MayasariL]

@Khoonono @WHO @CPC_usyd @ASBTE1 @ISBioFab @syd_health Thanks for sharing this Khoon. Looking forward to reading this!

[Mayasari Lim, PhD @MayasariL]

ARM says EU plans would take 90% of advanced therapies off the market https://t.co/oM3qW8TsFz

[Mayasari Lim, PhD @MayasariL]

Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy https://t.co/ZbA1jUcw3A via @whitehouse

[Mayasari Lim, PhD @MayasariL]

@BLLPHD Great book. Thoroughly enjoyed.

[Mayasari Lim, PhD @MayasariL]

ISCT partners to provide ‘urgent’ training programs for CGT workforce https://t.co/VoxL91Gxhd

[Mayasari Lim, PhD @MayasariL]

CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system - https://t.co/C35c3fwk4h

[Mayasari Lim, PhD @MayasariL]

@TomasGF90 @LehighU @dannykelly1978 @fjobrien @kentleach5 Congrats.

[FUJIFILM Biosciences @FUJIFILMBiosci]

We are pleased to announce the launch of our Manufacturing Science and Technology (MSAT) service to help you simplify and improve your cell culture media process workflow. Request the MSAT service and start simplifying your media preparation process now. https://t.co/2nEERC89rH

[Mayasari Lim, PhD @MayasariL]

A great #HBR IdeaCast listen on Building Successful Hybrid Teams #workplace #podcast https://t.co/F7fXUIsEu4

[Mayasari Lim, PhD @MayasariL]

Talent mobility is absolutely critical in retaining and growing best talents in any top organization - here are some great tips from #HBR on how to do this https://t.co/DLuPDjOp7x

[Mayasari Lim, PhD @MayasariL]

These Are The Top Priorities & Challenges For New CDER Director Patrizia Cavazzoni, M.D. https://t.co/13D0TvwNBy

[Mayasari Lim, PhD @MayasariL]

How industry is meeting FDA expectations on the impact of COVID-19 https://t.co/raYGSB9dXS via @[email protected]

[Mayasari Lim, PhD @MayasariL]

From Professor To Regenerative Medicine Company CEO

What a great story - years of dedication, sacrifice and resilience, and having the right people to make this happen

https://t.co/8ZpiskDIam

[Mayasari Lim, PhD @MayasariL]

How Pharma Executives View Future Business Travel https://t.co/u9Pvg6G2BN

[Mayasari Lim, PhD @MayasariL]

Why China's climate policy matters to us all https://t.co/ndN5I22SPs

[Mayasari Lim, PhD @MayasariL]

Interesting survey and insight on how this might impact diversity in the workplace post COVID

Don’t Let Employees Pick Their WFH Days https://t.co/RoZLoaPI9U